Our earlier studies, including the accompanying report, showed that Shp deletion attenuated obesity and NAFLD or NASH development in mice induced by a WD or methionine/choline-deficient diet. This evidence concerns the gene NR0B2 and metabolic dysfunction-associated steatohepatitis.